Industry: Pharmaceuticals, Biotechnology
KaloBios is a therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics. Its two most advanced drug candidates are KB001 and KB002. KB001 will treat life-threatening Pseudomonas lung infections, a common problem of Cystic Fibrosis and mechanically ventilated patients. KB002 is for the treatment of Rheumatoid Arthritis and other autoimmune diseases. To fully leverage the value of its technology platform, KaloBios is offering access to its antibody engineering capabilities via funded collaborations. ( www.kalobios.com )
KaloBios Pharmaceuticals , Inc.
3427 Hillview Avenue
Palo Alto, California 94304
USA
Tel: (650) 843-1897
Fax: (650) 843-1896
Instant Messenger: